Scheme To Launch Cancer Drugs At Reduced Costs To Be Launched On 29th Aug

Thiruvananthapuram: The State government’s initiative to make expensive cancer drugs and immunosuppressant drugs available at zero-profit price to consumers through Karunya pharmacies is being launched on Thursday.

The medicines will be distributed through special counters in selected Karunya pharmacy outlets. Chief Minister Pinarayi Vijayan will inaugurate the launch of zero-profit drugs online on Thursday. Health Minister Veena George will participate in the function to be held at the Karunya pharmacy at Thiruvananthapuram Government Medical College Hospital.

The State is making available 247 branded oncology drugs through special counters in 14 Karunya outlets in the first phase. The counter will be manned by newly appointed staff.

The State’s intervention to hold the drug price line will go a long way in reducing the out-of-pocket expenditure on health. Already, some 7,000-odd drugs are being sold at prices much less than the market price through the 74 Karunya outlets across the State.

It might be recalled that it was for the very purpose of providing drugs at lower costs that Karunya pharmacies were launched in 2012. At the time, some 107 cancer drugs were being given at much lower prices than the open market price through Karunya outlets. The Kerala Medical Services Corporation used to take a 7% margin then to cover its operational costs.

This time, the KMSC is attempting to sell cancer drugs at the prices at which it is procuring from the drug firm with zero profit margin.

While the scheme is being launched with much fanfare, many have expressed doubts about its sustainability, given the poor financials of the State. Also, unless the scheme is operated scrupulously clean and monitored closely, there are always possibilities for private pharma players to exploit the situation.

Related Posts

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

The Maharashtra Food and Drug Administration (FDA) seized 3,098.46 tonnes of food stock worth Rs 63.45 crore and suspended 954 food licences during a statewide enforcement drive in the past…

Stents to syringes: Serious harm reports surge, but makers remain unnamed

6-year data disclosed first time by Indian Pharmacopoeia Commission on CIC order The Indian Pharmacopoeia Commission (IPC) has, for the first time, disclosed the number of Serious Adverse Events (SAEs)…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

Stents to syringes: Serious harm reports surge, but makers remain unnamed

Stents to syringes: Serious harm reports surge, but makers remain unnamed

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Medicines that cure Us are making Our Environment Sick

Medicines that cure Us are making Our Environment Sick